Previous close | 0.7722 |
Open | 0.7969 |
Bid | 0.7709 x 200 |
Ask | 0.7835 x 200 |
Day's range | 0.7571 - 0.7969 |
52-week range | 0.5000 - 4.6700 |
Volume | |
Avg. volume | 616,906 |
Market cap | 42.542M |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
As you might know, Cara Therapeutics, Inc. ( NASDAQ:CARA ) last week released its latest full-year, and things did not...
Cara Therapeutics ( NASDAQ:CARA ) Full Year 2023 Results Key Financial Results Revenue: US$21.0m (down 50% from FY...
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]